Strategies used by helicobacter pylori to establish persistent infection
- PMID: 28522905
- PMCID: PMC5413782
- DOI: 10.3748/wjg.v23.i16.2870
Strategies used by helicobacter pylori to establish persistent infection
Abstract
Helicobacter pylori (H. pylori) is a Gram-negative and motile bacterium that colonizes the hostile microniche of the human stomach, then persists for the host's entire life, if not effectively treated. Clinically, H. pylori plays a causative role in the development of a wide spectrum of diseases including chronic active gastritis, peptic ulceration, gastric adenocarcinoma, and gastric mucosa-associated lymphoid tissue lymphoma. Due to the global distribution of H. pylori, it is no exaggeration to conclude that smart strategies are contributing to adaptation of the bacterium to its permanent host. Thirty-four years after the discovery of this bacterium, there are still many unanswered questions. For example, which strategies help the bacterium to survive in this inhospitable microniche? This question is slightly easier to answer if we presume the same clinical concept for both persistent infection and disease. Understanding the mechanisms governing H. pylori persistence will improve identification of the increased risk of diseases such as gastric cancer in patients infected with this bacterium. A well-defined and long-term equilibrium between the human host and H. pylori allows bacterial persistence in the gastric microniche; although this coexistence leads to a high risk of severe diseases such as gastric cancer. To escape the bactericidal activity of stomach acid, H. pylori secretes large amounts of surface-associated and cytosolic urease. The potential to avoid acidic conditions and immune evasion are discussed in order to explain the persistence of H. pylori colonization in the gastric mucosa, and data on bacterial genetic diversity are included. Information on the mechanisms related to H. pylori persistence can also provide the direction for future research concerning effective therapy and management of gastroduodenal disorders. The topics presented in the current review are important for elucidating the strategies used by H. pylori to help the bacterium persist in relation to the immune system and the many unfavorable features of living in the gastric microniche.
Keywords: Gastric cancer; Gastric microniche; Helicobacter pylori; Persistent infection.
Conflict of interest statement
Conflict-of-interest statement: Author declares no conflict of interests for this article.
Figures





Similar articles
-
Immune evasion strategies used by Helicobacter pylori.World J Gastroenterol. 2014 Sep 28;20(36):12753-66. doi: 10.3748/wjg.v20.i36.12753. World J Gastroenterol. 2014. PMID: 25278676 Free PMC article. Review.
-
Immune Evasion Strategies and Persistence of Helicobacter pylori.Curr Top Microbiol Immunol. 2017;400:53-71. doi: 10.1007/978-3-319-50520-6_3. Curr Top Microbiol Immunol. 2017. PMID: 28124149 Review.
-
Unraveling the factors and mechanism involved in persistence: Host-pathogen interactions in Helicobacter pylori.J Cell Biochem. 2019 Nov;120(11):18572-18587. doi: 10.1002/jcb.29201. Epub 2019 Jun 25. J Cell Biochem. 2019. PMID: 31237031 Review.
-
Structural modifications of Helicobacter pylori lipopolysaccharide: an idea for how to live in peace.World J Gastroenterol. 2014 Aug 7;20(29):9882-97. doi: 10.3748/wjg.v20.i29.9882. World J Gastroenterol. 2014. PMID: 25110419 Free PMC article. Review.
-
Mechanisms of persistence, innate immune activation and immunomodulation by the gastric pathogen Helicobacter pylori.Curr Opin Microbiol. 2020 Apr;54:1-10. doi: 10.1016/j.mib.2020.01.003. Epub 2020 Jan 31. Curr Opin Microbiol. 2020. PMID: 32007716 Review.
Cited by
-
The Single-Nucleotide Polymorphism of miR-27a rs895819 and the Expression of miR-27a in Helicobacter pylori-Related Diseases and the Correlation with the Traditional Chinese Medicine Syndrome.Evid Based Complement Alternat Med. 2022 Mar 15;2022:3086205. doi: 10.1155/2022/3086205. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35341140 Free PMC article.
-
Decreased IL-17RB expression impairs CD11b+CD11c- myeloid cell accumulation in gastric mucosa and host defense during the early-phase of Helicobacter pylori infection.Cell Death Dis. 2019 Jan 28;10(2):79. doi: 10.1038/s41419-019-1312-z. Cell Death Dis. 2019. PMID: 30692510 Free PMC article.
-
Innate Immunity in Helicobacter pylori Infection and Gastric Oncogenesis.Helicobacter. 2025 Mar-Apr;30(2):e70015. doi: 10.1111/hel.70015. Helicobacter. 2025. PMID: 40097330 Free PMC article. Review.
-
Host Cell Antimicrobial Responses against Helicobacter pylori Infection: From Biological Aspects to Therapeutic Strategies.Int J Mol Sci. 2022 Sep 19;23(18):10941. doi: 10.3390/ijms231810941. Int J Mol Sci. 2022. PMID: 36142852 Free PMC article. Review.
-
Microbes little helpers and suppliers for therapeutic asthma approaches.Respir Res. 2024 Jan 13;25(1):29. doi: 10.1186/s12931-023-02660-7. Respir Res. 2024. PMID: 38218816 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical